Vaccines

This COVID-19 roundup includes coverage of the FDA’s recent approval of bivalent booster vaccines for younger age groups, the use of COVID-19 PrEP and associated risk for the virus, an increase of...

The US Food and Drug Administration (FDA) approved the use of JYNNEOS vaccine for individuals who are at high risk of monkeypox infection.

The researchers sought to better understand the public health impact of immunization in children aged 10 years or younger in the United States.

Researchers examined the relationship between influenza vaccination and the development of Alzheimer disease in older US adults.

The US Food and Drug Administration has approved a new option for immunization against measles, mumps, and rubella.

The CDC Advisory Committee on Immunization Practices recently updated their vaccine recommendations for adults.

In this COVID-19 roundup, we discuss a fourth COVID-19 vaccine dose, how vaccination impacts women’s menstrual cycles, a multivariant COVID-19 booster, and updates on recommendations for pediatric COVID-19...

The Centers for Disease Control and Prevention’s Advisory Committee On Immunization Practices has released the 2020 recommended immunization schedule for adults.

Authors of a new study investigated the safety and immunogenicity of 3 formulations of an investigational vaccine, which contains RSV fusion protein engineered to preferentially maintain a prefusion...

Ève Dubé, PhD, answered our questions about vaccine hesitancy, best practices for increasing vaccination rates, and the best communication strategy to use with patients/caregivers—topics she also presented...